ARTICLE | Company News
Karo Bio genomics, metabolic news
September 20, 2004 7:00 AM UTC
KARO reduced its headcount by 20 to about 75 and restructured its research efforts to focus on advancing selected projects into clinical trials. The headcount cuts will mainly come from early drug dis...